HDAC1 and ovarian carcinoma: In another study, it was observed that HDAC1 was highly expressed in cisplatin-resistant ovarian cancer cells compared with a sensitive subline, also indicating reduced histone acetylation associated with cisplatin in ovarian cancer [111].